Over the past 20 years, there has been a shift in the way cancer care is delivered, with most patients treated as outpatients and sent home after chemotherapy sessions.
Plantar fasciitis is a common condition, with most patients treated successfully with nonoperative management.
Furthermore, the restrictive criteria of previous trials excluded most patients treated in daily practice.
Most patients treated with frontline immunochemotherapy relapse within a few years and do not usually respond to salvage chemotherapy.
Most patients treated with NIV had a history of chronic obstructive pulmonary disease (COPD) and / or were carriers of VNI with continuous positive pressure (CPAP) at home.
The Gaining Optimal Asthma ControL (GOAL) study demonstrated that salmeterol/fluticasone maintenance treatment can improve asthma control and reduce future risk compared with fluticasone alone, although the dose escalation design of this study meant that most patients treated with salmeterol/fluticasone were receiving the highest dose of ICS at the end of the study.
Most patients treated in developed countries have complete virological suppression.
Most patients treated with EXE experienced a reduction in body weight.
Most patients treated with CRRT maintain hemodynamic stability and tolerate the procedure well [ 12, 13].
Indeed, in most patients treated with peg-IFN, viral load initially declines in a biphasic manner.
However, most patients treated with conventional therapies will relapse after a short period, resulting in a poor prognosis.
